LPIN3 emerges as a diagnostic biomarker in Moyamoya disease revealing immune-lipid metabolic crosstalk.

Lu Z, Qiu X, Zhou L, Li X, Lu H, Wang S, Chen J, Bian L, Lin J, Zhao W, Zhao W, Gao X, Zhang J, Chen S, Li Z, Wang Z

Open source

DOI
10.3389/fgene.2026.1853818
Published
2026
Container
Frontiers in genetics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fgene.2026.1853818,
  title = {LPIN3 emerges as a diagnostic biomarker in Moyamoya disease revealing immune-lipid metabolic crosstalk.},
  author = {Lu Z and Qiu X and Zhou L and Li X and Lu H and Wang S and Chen J and Bian L and Lin J and Zhao W and Zhao W and Gao X and Zhang J and Chen S and Li Z and Wang Z},
  year = {2026},
  journal = {Frontiers in genetics},
  doi = {10.3389/fgene.2026.1853818},
  url = {https://doi.org/10.3389/fgene.2026.1853818}
}

RIS

TY  - JOUR
TI  - LPIN3 emerges as a diagnostic biomarker in Moyamoya disease revealing immune-lipid metabolic crosstalk.
AU  - Lu Z
AU  - Qiu X
AU  - Zhou L
AU  - Li X
AU  - Lu H
AU  - Wang S
AU  - Chen J
AU  - Bian L
AU  - Lin J
AU  - Zhao W
AU  - Zhao W
AU  - Gao X
AU  - Zhang J
AU  - Chen S
AU  - Li Z
AU  - Wang Z
PY  - 2026
JO  - Frontiers in genetics
DO  - 10.3389/fgene.2026.1853818
UR  - https://doi.org/10.3389/fgene.2026.1853818
ER  - 

APA

Z, L., X, Q., L, Z., X, L., H, L., S, W., J, C., L, B., J, L., W, Z., W, Z., X, G., J, Z., S, C., Z, L., & Z, W. (2026). LPIN3 emerges as a diagnostic biomarker in Moyamoya disease revealing immune-lipid metabolic crosstalk.. Frontiers in genetics. https://doi.org/10.3389/fgene.2026.1853818

Source records